Ugo Zanelli

569 total citations
25 papers, 443 citations indexed

About

Ugo Zanelli is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ugo Zanelli has authored 25 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Ugo Zanelli's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Ubiquitin and proteasome pathways (6 papers). Ugo Zanelli is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Ubiquitin and proteasome pathways (6 papers). Ugo Zanelli collaborates with scholars based in Italy, Germany and United Kingdom. Ugo Zanelli's co-authors include Elisa Turlizzi, David Hallifax, J. Brian Houston, J. Brian Houston, Carl Petersson, Pier Giovanni Gervasi, Djordje Müsil, Manja Friese‐Hamim, Michael P. Sanderson and Felix Rohdich and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ugo Zanelli

25 papers receiving 430 citations

Peers

Countries citing papers authored by Ugo Zanelli

Since Specialization

Citations

This map shows the geographic impact of Ugo Zanelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ugo Zanelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ugo Zanelli more than expected).

Fields of papers citing papers by Ugo Zanelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ugo Zanelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ugo Zanelli. The network helps show where Ugo Zanelli may publish in the future.

Co-authorship network of co-authors of Ugo Zanelli

This figure shows the co-authorship network connecting the top 25 collaborators of Ugo Zanelli. A scholar is included among the top collaborators of Ugo Zanelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ugo Zanelli. Ugo Zanelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a novel series of selective macrocyclic PKCTheta inhibitors 2024 ·Bioorganic & Medicinal Chemistry Letters ·Stefano Crosignani, Sébastien Campos, (unknown), Craig S. Harris, Eric P. A. Talbot, Haiyang Hu, Shun Wang, John Maclean, Ugo Zanelli, S. Taylor, Kevin M. Foote, Fériel Hacini‐Rachinel, Edwige Nicodème, Valérie Julia	2
2	155P Targeting colorectal cancer by sequestration of beta-catenin in nuclear condensates 2024 ·Annals of Oncology ·K. A. West, (unknown), (unknown), (unknown), Thomas F. Durand-Réville, (unknown), Ugo Zanelli, Isaac A. Klein, Ann Boija	1
3	M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models 2021 ·Molecular Cancer Therapeutics ·Michael P. Sanderson, Manja Friese‐Hamim, (unknown), Michael Busch, (unknown), Djordje Müsil, Felix Rohdich, Ugo Zanelli, Sondra L. Downey-Kopyscinski, Constantine S. Mitsiades, Oliver Schadt, Markus Klein, Christina Esdar	30
4	Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) 2021 ·Journal of Medicinal Chemistry ·Markus Klein, Michael Busch, Manja Friese‐Hamim, Stefano Crosignani, Thomas Fuchß, Djordje Müsil, Felix Rohdich, Michael P. Sanderson, Jeyaprakashnarayanan Seenisamy, (unknown), Ugo Zanelli, Philip Hewitt, Christina Esdar, Oliver Schadt	27
5	Abstract DDT02-01: First-time disclosure of M3258: A selective inhibitor of the immunoproteasome subunit LMP7 with potential for improved therapeutic utility in multiple myeloma compared to pan-proteasome inhibitors 2019 ·Michael J. Sanderson, Michael P. Busch, Christina Esdar, Manja Friese‐Hamim, Mireille Krier, Jianguo Ma, Djordje Müsil, Felix Rohdich, (unknown), Gina Walter, Ugo Zanelli, Oliver Schadt, Markus Klein	2
6	Building In Silico Models to Trigger Retesting: A Strategy on How to Use Predictive Models to Identify Potentially Incorrect In Vitro Intrinsic Clearance Results 2018 ·(unknown), Carl Petersson, Ugo Zanelli, Paul Czodrowski	2
7	Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance 2018 ·Toxicology in Vitro ·Varvara Gouliarmou, Alfonso M. Lostia, Sandra Coecke, Camilla Bernasconi, Jos Bessems, J.L.C.M. Dorne, Stephen Ferguson, Emanuela Testai, (unknown), J. Brian Houston, Mario Monshouwer, Andy Nong, Olavi Pelkonen, Siegfried Morath, Barbara A. Wetmore, Andrew Worth, Ugo Zanelli, (unknown), Maurice Whelan	24
8	Determination of low intrinsic clearancein vitro: the benefit of a novel internal standard in human hepatocyte incubations 2018 ·Xenobiotica ·Ugo Zanelli, (unknown), Carl Petersson	6
9	Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway 2015 ·European Journal of Medicinal Chemistry ·(unknown), Carmela Pratelli, (unknown), Massimiliano Salerno, Patrizia Tunici, Alessandra De Robertis, Silvia Valensin, (unknown), Marco Rossi, Annette Bakker, (unknown), (unknown), Elisa Turlizzi, (unknown), (unknown), Ugo Zanelli, (unknown), Matteo Magnani, M. Varrone	15
10	Expression of Tight Junction and Drug Efflux Transporter Proteins in an in vitro Model of Human Blood–Brain Barrier 2012 ·Frontiers in Psychiatry ·Chiara Cioni, Elisa Turlizzi, Ugo Zanelli, Giuseppe Oliveri, Pasquale Annunziata	26
11	Evaluation of the novel in vitro systems for hepatic drug clearance and assessment of their predictive utility 2012 ·Toxicology in Vitro ·J. Brian Houston, K Rowland‐Yeo, Ugo Zanelli	8
12	Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: Comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugs 2011 ·European Journal of Pharmaceutical Sciences ·David Hallifax, Elisa Turlizzi, Ugo Zanelli, J. Brian Houston	20
13	Comparison of Cryopreserved HepaRG Cells with Cryopreserved Human Hepatocytes for Prediction of Clearance for 26 Drugs 2011 ·Drug Metabolism and Disposition ·Ugo Zanelli, (unknown), David Hallifax, Elisa Turlizzi, J. Brian Houston	58
14	Fruitful Adrenergic α_2C-Agonism/α_2A-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence^, 2010 ·Journal of Medicinal Chemistry ·Fabio Del Bello, Laura Mattioli, (unknown), Mario Giannella, Alessandro Piergentili, Wilma Quaglia, (unknown), Marina Perfumi, Russell J. Thomas, Ugo Zanelli, Carla Marchioro, (unknown), Maria Pigini	28
15	Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Renza Roncarati, Carla Scali, Thomas A. Comery, Steven M. Grauer, (unknown), Hendrick Bothmann, Brian Jow, Dianne Kowal, Marco Gianfriddo, Cody Kelley, Ugo Zanelli, Chiara Ghiron, Simon N. Haydar, John Dunlop, Georg C. Terstappen	88
16	Evaluation of the role of intestinal and liver metabolism in the conversion of two different ester prodrugs of sanfetrinem to the parent drug in vitro and in vivo using different rat tissues and a surgically prepared rat model 2002 ·European Journal of Pharmaceutical Sciences ·Simone Braggio, (unknown), Matteo Sartori, (unknown), Ugo Zanelli, Laura Zonzini, Marcella Petrone	6
17	Stabilization of cytochrome P4502E1 protein by ethanol in primary hamster hepatocyte cultures 2000 ·Toxicology in Vitro ·Ugo Zanelli, Vincenzo Longo, Aldo Paolicchi, Pier Giovanni Gervasi	11
18	Induction of peroxisomal β-oxidation and P-450 4A-dependent activities by pivalic and trichloroacetic acid in rat liver and kidney 1996 ·Archives of Toxicology ·Ugo Zanelli, Paola Puccini, Daniela Acerbi, Paolo Ventura, Pier Giovanni Gervasi	20
19	Selective Depletion of Mitochondrial Glutathione Content by Pivalic Acid and Valproic Acid in Rat Liver 1996 ·Advances in experimental medicine and biology ·Ugo Zanelli, Paola Puccini, Daniela Acerbi, Paolo Ventura, Pier Giovanni Gervasi	1
20	Synthesis and toxicity to mammalian cells of the carrot dihydroisocoumarins 1993 ·Chemical Research in Toxicology ·Stefano Superchi, Dario Pini, Piero Salvadori, Flavia Marinelli, Giuseppe Rainaldi, Ugo Zanelli, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact